Vaccinex Reports Second Quarter 2022 Results and Provides
Promising initial responses in continuing Phase 1b/2 KEYNOTE B84 study of pepinemab with KEYTRUDA® in Recurrent/Metastatic Head and Neck Squamous Cell...
Source: globenewswire.com
Page 48 - Platform Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Platform Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Platform Technology Today - Breaking & Trending Today
Vaccinex Reports Second Quarter 2022 Results and Provides Corporate Update; Excellent Progress in Pepinemab Clinical Programs
15.08.2022 - Promising initial responses in continuing Phase 1b/2 KEYNOTE B84 study of pepinemab with KEYTRUDA in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Phase 2 SIGNAL-HD Study Published in Nature Medicine Patient enrollment continues in ...
Source: wallstreet-online.de
Xenetic Biosciences, Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update
Second quarter marked by deal to in-license DNase-based oncology platform which expands pipeline with well-defined and accelerated path to clinicAdvancing lead DNase program towards Phase 1 study for the
Source: finanznachrichten.de
2022 World Oil Awards finalists announced
The World Oil judging team selected finalists for each of the 18 categories from a pool of 303 nominations. The winners will be announced at the 2022 World Oil Awards ceremony on Oct. 13 in Houston, Texas.
Source: worldoil.com
Sinoveda Is a Health-Science Brand Committed to Synergy and Consistency
/PRNewswire/ -- Sinoveda is a Canadian health-science brand committed to Western precision with roots that go directly back to Eastern medicine. This unique...
Source: prnewswire.com